---
title: "Ex vivo machine perfusion of extended criteria donor livers: a Bayesian network meta-analysis"
authors:
  - Minseok Kang
  - Nguyen Thi Huyen Trang
  - Seonju Kim
  - Ji Hyun Shin
  - Yun Kyung Jung
  - Kyung Keun Lee
  - Kyeong Sik Kim
  - Boyoung Park
  - Dongho Choi
journal: (International Journal of Surgery)
year: 2025
tags:
  - ë…¼ë¬¸ë…¸íŠ¸
status: (ì½ëŠ” ì¤‘)
rating: 5
---

# ğŸ“ Ex vivo machine perfusion of extended criteria donor livers: a Bayesian network meta-analysis

## â… . ê¸°ë³¸ ì •ë³´ (Bibliographic Details)
- **ë…¼ë¬¸ ì œëª© (Title):** Ex vivo machine perfusion of extended criteria donor livers: a Bayesian network meta-analysis
- **ì €ì (Authors):** Minseok Kang, Nguyen Thi Huyen Trang, Seonju Kim, Ji Hyun Shin, Yun Kyung Jung, Kyung Keun Lee, Kyeong Sik Kim, Boyoung Park, Dongho Choi
- **í•™ìˆ ì§€ (Journal):** International Journal of Surgery
- **ê²Œì¬ ì—°ë„ (Year):** 2025
- **DOI / URL:** 10.1097/JS9.0000000000002525

## â…¡. ì—°êµ¬ ê°œìš”
- **ì—°êµ¬ ì¢…ë¥˜ (Study Type/Design):** Bayesian network meta-analysis
- **í•µì‹¬ ì§ˆë¬¸ (Key Questions):**
    1. ì´ ì—°êµ¬ê°€ ë‹µí•˜ê³ ì í•˜ëŠ” í•µì‹¬ ì§ˆë¬¸ì€ ë¬´ì—‡ì¸ê°€?
    - Different perfusion protocols (HOPE vs NMP)
    - Cannulation techniques (single vs dual)
    - Perfusion duration (long-term vs short-term)
    - Initiation timing (donor vs recipient hospital)

## â…¢. PICO ë¶„ì„
- **P (Patient/Problem):** Extended criteria donor (ECD) liver grafts
- **I (Intervention):** Ex vivo machine perfusion (HOPE and NMP)
- **C (Comparison):** Static cold storage (SCS), and different machine perfusion protocols compared with each other
- **O (Outcome):** Early allograft dysfunction (EAD), major complications, non-anastomotic biliary stricture (NAS), total biliary complications (TBC), acute cellular rejection (ACR), retransplantation, hepatic artery thrombosis (HAT), primary non-function (PNF), and renal replacement therapy (RRT)

## â…£. ì—°êµ¬ ë°©ë²• (Methods)
- **ì—°êµ¬ ëŒ€ìƒ (Study Population):** Randomized controlled trials (RCTs) and matched non-randomized studies (NRSs) comparing HOPE or NMP with SCS in adult liver transplants, conducted until December 2024. The study focused on extended criteria donor (ECD) liver grafts.
- **ì¤‘ì¬/ì‹¤í—˜ ì„¤ê³„ (Intervention/Experimental Design):** A Bayesian network meta-analysis was performed to assess the effects of varying temperature settings (hypothermic vs. normothermic), cannulation techniques (single vs. dual), and perfusion duration (short-term vs. long-term).
- **ì£¼ìš” ì¸¡ì • ë³€ìˆ˜ (Primary Endpoint / Key Variables):** Early allograft dysfunction (EAD), major complications, non-anastomotic biliary stricture (NAS), total biliary complications (TBC), acute cellular rejection (ACR), retransplantation, hepatic artery thrombosis (HAT), primary non-function (PNF), and renal replacement therapy (RRT).
- **í†µê³„ ë¶„ì„ (Statistical Analysis):** [[Bayesian Network Meta Analysis]] was performed using the gemtc package in R Studio (v4.3.3). The deviance information criterion was used to choose between random and fixed effects models. -- [[Meta-Analysis]]

## â…¤. ì£¼ìš” ê²°ê³¼ (Key Findings/Results)
- HOPE is more effective than NMP in preventing EAD, TBC, NAS, and ACR in ECD grafts.
- Both single and dual HOPE are effective, and dual HOPE did not show superiority over single HOPE.
- Early initiation of NMP (long-term NMP) may prevent NAS compared to short-term NMP.
- Compared to SCS, HOPE reduced the risks of EAD, major complications, and ACR (high-certainty evidence), as well as NAS, TBC, and retransplantation (moderate-certainty evidence).
- Compared to NMP, HOPE reduced the risks of EAD, NAS, TBC, and ACR (moderate-certainty evidence).
- **í•µì‹¬ ë„í‘œ/ê·¸ë¦¼ (Key Figures/Tables):**
    - Figure 3 & 5: Forest plots summarizing the network meta-analysis. HOPE consistently shows benefits over SCS and NMP for most outcomes. Long-term HOPE shows more significant benefits than short-term HOPE.
    ![[Pasted image 20251006014950.png]]
	 ![[Pasted image 20251006015139.png]]
	- Figure 4: Single vs Dual HOPE via Network MA
	![[Pasted image 20251006015334.png]]
	* Figure2: Network map & Rankogram
	![[Pasted image 20251006015519.png]]
## â…¥. í•œê³„ì  (Limitations)
- The **difference between portable and non-portable devices** was not addressed.
- The analysis of graft loss and patient death was limited due to their multifactorial etiology and rarity.
- The **perfusion-to-preservation time ratio was calculated from median or mean values,** which may not fully represent the individual studies.
- The coherence assumption was weakly verified due to the lack of direct comparison studies between different machine perfusion protocols.

## â…¦. ë‚˜ì˜ ìƒê° ë° ì—°ê²° (My Thoughts & Connections)
- **í•µì‹¬ ë©”ì‹œì§€ (Take-home Message):**
    - Extended criteria donor ê°„ ì´ì‹ì—ì„œ, ì €ì˜¨ ì‚°ì†Œ ê¸°ê³„ê´€ë¥˜(HOPE)ëŠ” ì „í†µì ì¸ ëƒ‰ì¥ ë³´ê´€(SCS)ì´ë‚˜ ì •ìƒì˜¨ ê¸°ê³„ê´€ë¥˜(NMP)ë³´ë‹¤ ì£¼ìš” í•©ë³‘ì¦ì„ ì¤„ì´ëŠ” ë° ë” íš¨ê³¼ì ì¸ ì¥ê¸° ë³´ì¡´ ì „ëµìœ¼ë¡œ ë³´ì¸ë‹¤.
- **ë‚˜ì˜ ë¹„íŒì  ì‚¬ê³  (Critical Thoughts):**
    - ì´ ì—°êµ¬ëŠ” **ê°„ì ‘ ë¹„êµì— ì˜ì¡´í•˜ëŠ” ë„¤íŠ¸ì›Œí¬ ë©”íƒ€ë¶„ì„**ì´ë‹¤. ë‹¤ë¥¸ ê¸°ê³„ê´€ë¥˜ í”„ë¡œí† ì½œ(ì˜ˆ: HOPE ëŒ€ NMP) ê°„ì˜ ì§ì ‘ì ì¸ ë¹„êµ ì—°êµ¬ê°€ ë¶€ì¡±í•˜ë‹¤ëŠ” ì ì´ ì¤‘ìš”í•œ í•œê³„ì´ë‹¤.
    - ê´€ë¥˜ ì‹œê°„ì„ **ë‹¨ìˆœíˆ perfusion-to-preservation time ratioì˜ 50ë²ˆì§¸ ë°±ë¶„ìœ„ìˆ˜ë¥¼ ê¸°ì¤€ìœ¼ë¡œ 'ì¥ê¸°'ì™€ 'ë‹¨ê¸°'ë¡œ ë‚˜ëˆˆ ê²ƒ**ì€ ë‹¤ì†Œ ì„ì˜ì ì´ë©°, ì„ìƒì ìœ¼ë¡œ ì˜ë¯¸ ìˆëŠ” ì°¨ì´ë¥¼ ë°˜ì˜í•˜ì§€ ëª»í•  ìˆ˜ ìˆë‹¤.
- **ì—°ê²°í•  ë…¸íŠ¸ (Connections):**
    - [[(ë…¼ë¬¸) ì‹ ì¥ ê¸°ê³„ê´€ë¥˜ ë°©ì‹ RCTì˜ MA]] 
    - `[[Organ Preservation]]`
    - [[Liver Transplantation]]
    - [[ì˜ê³¼í•™ì RMSC]] 
- **í›„ì† ì§ˆë¬¸ (Future Questions):**
    - **HOPEì˜ ìµœì  ì§€ì† ì‹œê°„ê³¼ ì‹œì‘ ì‹œì **ì€ ì–¸ì œì¸ê°€?
    - HOPEì˜ ì´ì ì€ ë‹¤ì–‘í•œ ìœ í˜•ì˜ extended criteria donor(ì˜ˆ: DCD ëŒ€ ê³ ë ¹ ê¸°ì¦ì)ì— ê±¸ì³ ì¼ê´€ë˜ê²Œ ë‚˜íƒ€ë‚˜ëŠ”ê°€?
    - **HOPEê°€ NMPë³´ë‹¤ ìš°ìˆ˜í•œ êµ¬ì²´ì ì¸ ìƒë¬¼í•™ì  ê¸°ì „ì€ ë¬´ì—‡ì¸ê°€?**
    - ê´€ë¥˜ ì‹œê°„

## â…§. ì„¸ë¶€ ë¶„ì„: Long-term HOPE vs. Short-term HOPE
ì´ ë…¼ë¬¸ì€ long-term HOPEì™€ short-term HOPEë¥¼ ì§ì ‘ ë¹„êµí•œ ê²°ê³¼ë„ ì œì‹œí•©ë‹ˆë‹¤.

- **1. ì›ë°œì„± ë¬´ê¸°ëŠ¥(PNF, Primary Non-Function):**
    - ê°€ì¥ ì¤‘ìš”í•œ ë°œê²¬ìœ¼ë¡œ, Long-term HOPEê°€ Short-term HOPEì— ë¹„í•´ **PNF ë°œìƒ ìœ„í—˜ì„ ìœ ì˜ë¯¸í•˜ê²Œ ê°ì†Œì‹œí‚¨ë‹¤**ëŠ” ì ì„ ë†’ì€ í™•ì‹¤ì„±(high-certainty)ì˜ ê·¼ê±°ë¡œ í™•ì¸í–ˆìŠµë‹ˆë‹¤ (Figure 5 ì°¸ì¡°).

- **2. ê¸°íƒ€ ê²°ê³¼ ì§€í‘œ:**
    - PNFë¥¼ ì œì™¸í•œ ë‹¤ë¥¸ ì£¼ìš” ê²°ê³¼ë“¤(ì˜ˆ: ì¡°ê¸° ì´ì‹í¸ ê¸°ëŠ¥ì¥ì• (EAD), ì£¼ìš” í•©ë³‘ì¦, ë¹„ë¬¸í•©ë¶€ ë‹´ë„ í˜‘ì°©(NAS), ì´ ë‹´ë„ê³„ í•©ë³‘ì¦(TBC) ë“±)ì— ëŒ€í•´ì„œëŠ”, long-term HOPEê°€ short-term HOPEë³´ë‹¤ ëª…ë°±íˆ ìš°ì›”í•˜ë‹¤ëŠ” ê·¼ê±°ë¥¼ ì°¾ì§€ ëª»í–ˆìŠµë‹ˆë‹¤ (ê·¼ê±° ìˆ˜ì¤€ì´ ë‚®ê±°ë‚˜ ë§¤ìš° ë‚®ìŒ).

- **3. ê²°ë¡ :**
    - ë”°ë¼ì„œ, ì´ ë©”íƒ€ë¶„ì„ì—ì„œ ë‘ ê·¸ë£¹ ê°„ì˜ ì§ì ‘ ë¹„êµë¥¼ í†µí•´ ì…ì¦ëœ long-term HOPEì˜ ëª…í™•í•œ ì„ìƒì  ì´ì ì€ **PNF ì˜ˆë°© íš¨ê³¼**ì— ì§‘ì¤‘ë˜ì–´ ìˆìŠµë‹ˆë‹¤.
---